BIM
WST icon

BlackRock Investment Management’s West Pharmaceutical WST Stock Holding History

BlackRock Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$21.1M Buy
249,107
+41,751
+20% +$3.28M 0.02% 652
2016
Q3 		$15.4M Sell
207,356
-652
-0.3% -$51.8K 0.02% 732
2016
Q2 		$15.8M Sell
208,008
-213,810
-51% -$15.6M 0.02% 675
2016
Q1 		$29.2M Buy
421,818
+11,712
+3% +$705K 0.04% 410
2015
Q4 		$24.7M Buy
410,106
+1,240
+0.3% +$74.6K 0.03% 468
2015
Q3 		$22.1M Buy
408,866
+133,094
+48% +$7.76M 0.03% 492
2015
Q2 		$16M Buy
275,772
+41,487
+18% +$2.32M 0.02% 700
2015
Q1 		$14.1M Buy
234,285
+3,432
+1% +$183K 0.02% 743
2014
Q4 		$12.3M Sell
230,853
-1,704
-0.7% -$85.2K 0.02% 811
2014
Q3 		$10.4M Buy
232,557
+672
+0.3% +$28.6K 0.01% 893
2014
Q2 		$9.78M Buy
231,885
+1,902
+0.8% +$81.5K 0.01% 982
2014
Q1 		$10.1M Buy
229,983
+2,203
+1% +$104K 0.01% 911
2013
Q4 		$11.2M Sell
227,780
-4,460
-2% -$209K 0.02% 824
2013
Q3 		$9.56M Buy
232,240
+13,322
+6% +$508K 0.02% 866
2013
Q2 		$7.69M Buy
+218,918
New +$7.2M 0.01% 928

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Investment Management's WST Position: Q4 2016 in Review

BlackRock Investment Management increased its West Pharmaceutical (WST) stake by 20% in Q4 2016, buying an estimated $3.28M and bringing the position to 249,107 shares worth $21.1M. The position accounts for 0.02% of the portfolio, ranked #652.

BlackRock Investment Management first reported a position in WST in Q2 2013 and has held it in 15 quarters since. The position peaked at $29.2M in Q1 2016. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

  • BlackRock Investment Management held 249,107 shares of West Pharmaceutical worth $21.1M as of Q4 2016.
  • BlackRock Investment Management bought 41,751 West Pharmaceutical shares in Q4 2016, an estimated $3.28M.
  • West Pharmaceutical made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #652 holding.
  • BlackRock Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's West Pharmaceutical position peaked at $29.2M in Q1 2016.
  • 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.